BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37159542)

  • 21. Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts.
    Bryan JL; Hogan J; Lindsay JA; Ecker AH
    J Subst Abuse Treat; 2021 Mar; 122():108254. PubMed ID: 33509412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization.
    Ecker AH; Lang B; Hogan J; Cucciare MA; Lindsay J
    J Subst Abuse Treat; 2020 Feb; 109():46-49. PubMed ID: 31856950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis use disorder in relation to socioeconomic factors and psychiatric comorbidity: A cluster analysis of three million individuals born in 1970-2000.
    Rabiee R; Lundin A; Agardh E; Allebeck P; Danielsson AK
    Scand J Public Health; 2023 Feb; 51(1):82-89. PubMed ID: 36120841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study.
    Hill ML; Loflin M; Nichter B; Norman SB; Pietrzak RH
    Addict Behav; 2021 Sep; 120():106963. PubMed ID: 33964583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use disorder in patients with chronic pain: overestimation and underestimation in a cross-sectional observational study in 3 German pain management centres.
    Bialas P; Böttge-Wolpers C; Fitzcharles MA; Gottschling S; Konietzke D; Juckenhöfel S; Madlinger A; Welsch P; Häuser W
    Pain; 2023 Jun; 164(6):1303-1311. PubMed ID: 36327134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis use disorder treatment use and perceived treatment need in the United States: Time trends and age differences between 2002 and 2019.
    Askari MS; Keyes KM; Mauro PM
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109154. PubMed ID: 34741874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.
    Lapham GT; Matson TE; Bobb JF; Luce C; Oliver MM; Hamilton LK; Bradley KA
    JAMA Netw Open; 2023 Aug; 6(8):e2328934. PubMed ID: 37642968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.
    De Aquino JP; Sofuoglu M; Stefanovics E; Rosenheck R
    Am J Drug Alcohol Abuse; 2019; 45(5):527-537. PubMed ID: 31112429
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.
    Patel RS; Goyal H; Satodiya R; Tankersley WE
    Subst Use Misuse; 2020; 55(2):281-290. PubMed ID: 31573379
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessing the diagnostic utility of the Cannabis Use Disorder Identification Test - Revised (CUDIT-R) among veterans with medical and non-medical cannabis use.
    Myers MG; Ganoczy D; Walters HM; Pfeiffer PN; Ilgen MA; Bohnert KM
    Drug Alcohol Depend; 2023 Jun; 247():109876. PubMed ID: 37130467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).
    Browne KC; Stohl M; Bohnert KM; Saxon AJ; Fink DS; Olfson M; Cerda M; Sherman S; Gradus JL; Martins SS; Hasin DS
    Am J Psychiatry; 2022 Jan; 179(1):26-35. PubMed ID: 34407625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016.
    Weinberger AH; Pacek LR; Wall MM; Zvolensky MJ; Copeland J; Galea S; Nahvi S; Moeller SJ; Hasin DS; Goodwin RD
    Drug Alcohol Depend; 2018 Oct; 191():45-51. PubMed ID: 30077055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of cannabis use disorder among individuals using medical cannabis at admission to inpatient treatment for substance use disorders.
    N S Gendy M; Taisir R; Sousa S; Costello J; Rush B; Busse JW; Mackillop J
    Addict Behav; 2023 Jul; 142():107667. PubMed ID: 36893511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent pain and comorbidity among Operation Enduring Freedom/Operation Iraqi Freedom/operation New Dawn veterans.
    Higgins DM; Kerns RD; Brandt CA; Haskell SG; Bathulapalli H; Gilliam W; Goulet JL
    Pain Med; 2014 May; 15(5):782-90. PubMed ID: 24548466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide DNA methylation analysis of cannabis use disorder in a veteran cohort enriched for posttraumatic stress disorder.
    Garrett ME; Dennis MF; Bourassa KJ; ; Hauser MA; Kimbrel NA; Beckham JC; Ashley-Koch AE
    Psychiatry Res; 2024 Mar; 333():115757. PubMed ID: 38309009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying HIV care enrollees at-risk for cannabis use disorder.
    Hartzler B; Carlini BH; Newville H; Crane HM; Eron JJ; Geng EH; Mathews WC; Mayer KH; Moore RD; Mugavero MJ; Napravnik S; Rodriguez B; Donovan DM
    AIDS Care; 2017 Jul; 29(7):846-850. PubMed ID: 28006972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition.
    Mills L; Lintzeris N; O'Malley M; Arnold JC; McGregor IS
    Drug Alcohol Rev; 2022 Jul; 41(5):1095-1108. PubMed ID: 35172040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample.
    Matson TE; Williams EC; Lapham GT; Oliver M; Hallgren KA; Bradley KA
    Drug Alcohol Depend; 2023 Oct; 251():110946. PubMed ID: 37688980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States.
    Kerridge BT; Mauro PM; Chou SP; Saha TD; Pickering RP; Fan AZ; Grant BF; Hasin DS
    Drug Alcohol Depend; 2017 Dec; 181():223-228. PubMed ID: 29107786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).
    Buckner JD; Heimberg RG; Schneier FR; Liu SM; Wang S; Blanco C
    Drug Alcohol Depend; 2012 Jul; 124(1-2):128-34. PubMed ID: 22266089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.